International Journal of Medical Toxicology and Forensic Medicine

[1] United Nations Office on Drugs and Crime (UNODC). World Drug Report 2025. Vienna: United Nations Publication; 2025. [Link]

[2] Sarollahi R, Ghaderi A, Banafshe H R, Atlasi M A. Lifetime, Last Month and Excessive Prevalence of Addictive Substances Consumption Among the General Population and University Students in the City of Tehran. Int J High Risk Behav Addict. 2025;14(3):e159843. [DOI: 10.5812/ijhrba-159843]

[3] Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560-79. [DOI: 10.1016/S0140-6736(19)32229-9]

[4] Zarei F, Simani M, Rajabi Moghaddam H, Ghaderi A. A review of cardiovascular diseases in substance use disorders: current knowledge and future perspectives. Addict Health. 2025;17:1722. [DOI: 10.34172/ahj.1722]

[5] Baghaie H, Kisely S, Forbes M, Sawyer E, Siskind DJ. A systematic review and meta-analysis of the association between poor oral health and substance abuse. Addiction. 2017;112(5):765-79. [DOI: 10.1111/add.13754]

[6] Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral Health of Drug Abusers: A Review of Health Effects and Care. Iran J Public Health. 2013;42(9):929-40. [DOI: 10.26060654]

[7] Esfahanian F, Fallah M, Vahed N, Masoumzadeh S, Ghaderi A, Asadollahi Shahir A A. A Systematic Review of Dermatologic Manifestations of Illicit Substance Use: Converging Vascular, Immune, and Behavioral Pathways. Int J Med Toxicol Forensic Med. 2026;16:1-14. [DOI: 10.22037/ijmtfm.v16.51860]

[8] Soleimani A, Farshchi HK, Mirzavi F, Zamani P, Ghaderi A, Amini Y, et al. The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. Biochimie. 2020;176:21-30. [DOI: 10.1016/j.biochi.2020.06.001]

[9] John DA, Adams EA, McGowan LJ, Joyes EC, Richmond C, Beyer FR, et al. Factors influencing implementation and sustainability of interventions to improve oral health and related health behaviors in adults experiencing severe and multiple disadvantage: a mixed-methods systematic review. BMJ Open. 2024;14(1):e080160. [DOI: 10.1136/bmjopen-2023-080160]

[10] Esposito MM, Kalinowski J, Mikhaeil M. The Effects of Recreational and Pharmaceutical Substance Use on Oral Microbiomes and Health. Bacteria. 2024;3(3):209-22. [DOI: 10.3390/bacteria3030015]

[11] Zhao Y, Zhang C, Chang X, Zhang J, Shu C, Lin C, et al. Causal association between periodontitis and systemic diseases: a systematic review and meta-analysis of Mendelian randomization studies. BMC Oral Health. 2026;26(1):383. [DOI: 10.1186/s12903-026-07725-9]

[12] Wang L, Cai Y, Ruan Y, Zhang F, Yu H, Gao Y. Research progress on the bidirectional association between periodontal disease and depression/anxiety. J Prev Treat Stomatol Dis. 2026;34(3):281-91. [DOI: 10.12016/j.issn.2096-1456.202550193]

[13] Barkus A, Baltrūnienė V, Barkienė L, Baušienė J, Baltrūnas T, Brazys M, et al. Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies. J Neurochem. 2025;169(7):e70165. [DOI: 10.1111/jnc.70165]

[14] Ibrahim SM, Khalel AM. Using the Immune System for Effective Periodontal and Caries Management. Biomed Res Int. 2025;2025:6385469. [DOI: 10.1155/bmri/6385469]

[15] Patil S, Bhandi S, Licari FW. Illicit and Recreational Drug Abuse and Oral Health. In: Prabhu S, Warnakulasuriya S, Bhardwaj S, editors. Lifestyle in Oral Health and Disease. Cham: Springer;2025. [DOI: 10.1007/978-3-032-05888-1_11]

[16] Yazdanian M, Armoon B, Noroozi A, Mohammadi R, Bayat AH, Ahounbar E, et al. Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis. BMC Oral Health. 2020;20(1):44. [DOI: 10.1186/s12903-020-1010-3]

[17] Rossow I. Illicit drug use and oral health. Addiction. 2021;116(11):3235-42. [DOI: 10.1111/add.15360]

[18] McGowan LJ, John DA, Kenny RPW, Joyes EC, Adams EA, Shabaninejad H, et al. Improving oral health and related health behaviors (substance use, smoking, diet) in people with severe and multiple disadvantage: A systematic review of effectiveness and cost-effectiveness of interventions. PLoS One. 2024;19(4):e0298885. [DOI: 10.1371/journal.pone.0298885]

[19] Chichua N, Grigol D, Vladimer M. Oral health in intravenous drug addicts and the role of dental professionals. Transl Clin Med Georgian Med J. 2024;9(2):50-4. [Link]

[20] Hossain KMS, Kakoli AS, Mesbah FB, Mian AH. Prevalence of oral and dental diseases and oral hygiene practices among illicit drug abusers. J Alcohol Drug Depend. 2018;6(1). [DOI: 10.4172/2329-6488.1000301]

[21] Skallevold HE, Rokaya N, Wongsirichat N, Rokaya D. Importance of oral health in mental health disorders: An updated review. J Oral Biol Craniofac Res. 2023;13(5):544-52. [DOI: 10.1016/j.jobcr.2023.06.003]

[22] Cai V, Peng Ng C, Zhao J, Siskind D, Kisely S. A Systematic Review and Meta-Analysis of the Association Between Periodontal Disease and Severe Mental Illness. Psychosom Med. 2022;84(7):836-47. [DOI: 10.1097/PSY.0000000000001102]

[23] Pabst A, Castillo-Duque JC, Mayer A, Klinghuber M, Werkmeister R. Meth Mouth-A Growing Epidemic in Dentistry? Dent J (Basel). 2017;5(4):29. [DOI: 10.3390/dj5040029]

[24] Newell LR, Fouillen KJ, Orliaguet M, Kichenin J, Boisramé S. Oral health effects of ecstasy (MDMA) and methamphetamine: a narrative review. Front Oral Health. 2025;6:1645445. [DOI: 10.3389/froh.2025.1645445]

[25] Saini T, Edwards PC, Kimmes NS, Carroll LR, Shaner JW, Dowd FJ. Etiology of xerostomia and dental caries among methamphetamine abusers. Oral Health Prev Dent. 2005;3(3):189-95. [DOI: 10.3290/j.ohpd.a10643]

[26] Ye T, Sun D, Dong G, Xu G, Wang L, Du J, et al. The effect of methamphetamine abuse on dental caries and periodontal diseases in an Eastern China city. BMC Oral Health. 2018;18(1):8. [DOI: 10.1186/s12903-017-0463-5]

[27] Shetty V, Harrell L, Murphy DA, Vitero S, Gutierrez A, Belin TR, et al. Dental disease patterns in methamphetamine users: Findings in a large urban sample. J Am Dent Assoc. 2015;146(12):875-85. [DOI: 10.1016/j.adaj.2015.09.012]

[28] Morales-Valladares GA, Gavilanez-Gaibor AE, Lanas Terán GA, Tapia-Tapia GN. Oral and Maxillofacial Effects of Chronic Cocaine Use: A Systematic Review. Univ Odontol. 2025;44. [DOI: 10.11144/Javeriana.uo44.oemc]

[29] Rendon LF, Malta S, Leung J, Badenes R, Nozari A, Bilotta F. Cocaine and Ischemic or Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Clinical Evidence. J Clin Med. 2023;12(16):5207. [DOI: 10.3390/jcm12165207]

[30] Melo CAA, Guimarães HRG, Medeiros RCF, Souza GCA, Santos PBDD, Tôrres ACSP. Oral changes in cocaine abusers: an integrative review. Braz J Otorhinolaryngol. 2022;88(4):633-41. [DOI: 10.1016/j.bjorl.2021.04.011]

[31] Herrmann G, Müller K, Behr M, Hahnel S. Xerostomie und ihr Einfluss auf die mundgesundheitsbezogene Lebensqualität. Z Gerontol Geriatr. 2017;50(2):145-50. [DOI: 10.1007/s00391-015-0968-y]

[32] Bettinger JJ, Friedman BC. Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies. Palliat Med Rep. 2024;5(1):70-80. [DOI: 10.1089/pmr.2023.0049]

[33] Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol. 2011;6(4):442-65. [DOI: 10.1007/s11481-011-9292-5]

[34] Badescu MC, Rezus E, Ciocoiu M, Badulescu OV, Butnariu LI, Popescu D, et al. Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications. Int J Mol Sci. 2022;23(2):640. [DOI: 10.3390/ijms23020640]

[35] Molavi N, Ghaderi A, Banafshe HR. Examining Metabolic Profiles in Opioid-Dependent Patient. Int J Med Toxicol Forensic Med. 2020;10(3):28681. [DOI: 10.32598/ijmtfm.v10i3.28681]

[36] Karyadi E, Abdul Kodir AI, Zahiro NF, Bouty AAV. The effect of drug users on periodontal health: literature review. Odonto Dent J. 2023;10:106. [DOI: 10.30659/odj.10.0.106-113]

[37] Preet A, Ganju RK, Groopman JE. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 2008;27(3):339-46. [DOI: 10.1038/sj.onc.1210641]

[38] Chisini LA, Cademartori MG, Francia A, Mederos M, Grazioli G, Conde MCM, et al. Is the use of Cannabis associated with periodontitis? A systematic review and meta-analysis. J Periodontal Res. 2019;54(4):311-7. [DOI: 10.1111/jre.12639]

[39] Bifulco M, Laezza C, Pisanti S, Gazzerro P. Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol. 2006;148(2):123-35. [DOI: 10.1038/sj.bjp.0706632]

[40] Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, et al. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol. 2014;48(1):1-10. [DOI: 10.2478/raon-2013-0057]

[41] Campana MD, de Paolis G, Sammartino G, Bucci P, Aliberti A, Gasparro R. Cannabinoids: Therapeutic Perspectives for Management of Orofacial Pain, Oral Inflammation and Bone Healing-A Systematic Review. Int J Mol Sci. 2025;26(8):3766. [DOI: 10.3390/ijms26083766]

[42] Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019;2(11):e1916318. [DOI: 10.1001/jamanetworkopen.2019.16318]

[43] Gandhi UH, Benjamin A, Gajjar S, Hirani T, Desai K, Suhagia BB, et al. Alcohol and Periodontal Disease: A Narrative Review. Cureus. 2024;16(6):e62270. [DOI: 10.7759/cureus.62270]

[44] Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777-89. [DOI: 10.1093/jnci/djk179]

[45] Ferraguti G, Terracina S, Petrella C, Greco A, Minni A, Lucarelli M, et al. Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents. Antioxidants (Basel). 2022;11(1):145. [DOI: 10.3390/antiox11010145]

[46] Stornetta A, Guidolin V, Balbo S. Alcohol-Derived Acetaldehyde Exposure in the Oral Cavity. Cancers (Basel). 2018;10(1):20. [DOI: 10.3390/cancers10010020]

[47] Booker B, Hassan I. Perioperative decision-making for patients with known alcohol-related liver disease undergoing emergency surgery. Adv Perioper Care. 2026;1(1). [DOI: 10.14324/111.444/apoc.3707]

[48] Boroomand E, Movahed E, Siahvoshi S, Farzan P, Omran SP, Azizi M, et al. The association between alcohol consumption and dental implant failure: a systematic review and meta-analysis. Oral Maxillofac Surg. 2026;30(1):41. [DOI: 10.1007/s10006-026-01531-x]

[49] Jenkins MJA, Kinsella SM, Wiles MD, Srivastava B, Griffiths62270. [DOI: 10.7759/cureus.62270]

[44] Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777-89. [DOI: 10.1093/jnci/djk179]

[45] Ferraguti G, Terracina S, Petrella C, Greco A, Minni A, Lucarelli M, et al. Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents. Antioxidants (Basel). 2022;11(1):145. [DOI: 10.3390/antiox11010145]

[46] Stornetta A, Guidolin V, Balbo S. Alcohol-Derived Acetaldehyde Exposure in the Oral Cavity. Cancers (Basel). 2018;10(1):20. [DOI: 10.3390/cancers10010020]

[47] Booker B, Hassan I. Perioperative decision-making for patients with known alcohol-related liver disease undergoing emergency surgery. Adv Perioper Care. 2026;1(1). [DOI: 10.14324/111.444/apoc.3707]

[48] Boroomand E, Movahed E, Siahvoshi S, Farzan P, Omran SP, Azizi M, et al. The association between alcohol consumption and dental implant failure: a systematic review and meta-analysis. Oral Maxillofac Surg. 2026;30(1):41. [DOI: 10.1007/s10006-026-01531-x]

[49] Jenkins MJA, Kinsella SM, Wiles MD, Srivastava B, Griffiths C, Lewin J, et al. Peri-operative identification and management of patients with unhealthy alcohol intake. Anaesthesia. 2ontal Health and Psychiatric Disorders. Curr Oral Health Rep. 2023;10(3):111-6. [DOI: 10.1007/s40496-023-00339-y]

[56] Marsh PD, Head DA, Devine DA. Ecological approaches to oral biofilms: control without killing. Caries Res. 2015;9(Suppl 1):46-54. [DOI: 10.1159/000377732]

[57] Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspectives. J Dent Res. 2011;90(3):294-303. [DOI: 10.1177/0022034510379602]

[58] Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002-17. [DOI: 10.1128/JB.00542-10]

[59] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30-44. [DOI: 10.1038/nri3785]

[60] Ray RR. Periodontitis: An Oral Disease with Severe Consequences. Appl Biochem Biotechnol. 2023;195(1):17-32. [DOI: 10.1007/s12010-022-04127-9]

[61] Cuberos M, Chatah EM, Baquerizo HZ, Weinstein G. Dental management of patients with substance use disorder. Clin Dent Rev. 2020;4:14. [DOI: 10.1007/s41894-020-00078-8]

[62] Etminan M, Rezaeianzadeh R, Kezouh A, Aminzadeh K. Association Between Sublingual Buprenorphine-Naloxone Exposure and Dental Disease. JAMA. 2022;328(22):2269-71. [DOI: 10.1001/jama.2022.17485]

[63] Tuan WJ, Clebak KT, Jawadi E, Snyder J, Zgierska AE. Risk of Oral Health Problems in Adults With Opioid Use Disorder Treated With Transmucosal Buprenorphine. J Addict Med. 2025;19(5):529-35. [DOI: 10.1097/ADM.0000000000001453]

[64] Black AC, Becker WC. Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al. J Addict Med. 2025; 19(5):507-9. [DOI: 10.1097/ADM.0000000000001452]

[65] Segelnick SL, Weinberg MA. Orally dissolving buprenorphine for opioid use disorder linked to caries. J Am Dent Assoc. 2024;155(7):561-4. [DOI: 10.1016/j.adaj.2024.03.001]

[66] Pei XM, Zhou LX, Tsang MW, Tai WC, Wong SC. The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review. Int J Mol Sci. 2024;25(23):12815. [DOI: 10.3390/ijms252312815]

[67] Quaranta A, D’Isidoro O, Piattelli A, Hui WL, Perrotti V. Illegal drugs and periodontal conditions. Periodontol 2000. 2022;90(1):62-87. [DOI: 10.1111/prd.12450]

[68] Aldosari LIN, Hassan SAB, Alshahrani AA, Alshadidi AAF, Ronsivalle V, Marrapodi MM, et al. Prevalence of temporomandibular disorders among psychoactive substances abusers: A systematic review and meta-analysis. J Oral Rehabil. 2023;50(9):894-901. [DOI: 10.1111/joor.13513]

[69] Souto Nóbrega WF, da Silva GCB, de Oliveira MEC, Cavalcanti SDÁLB. Beyond Health Services: The Persistent Impact of Early Substance Abuse on Oral Health-related Quality of Life. J Int Soc Prev Community Dent. 2026;16(1):78-87. [DOI: 10.4103/jispcd.jispcd_80_25]

[70] Quinlan J, Cox F. Akutschmerztherapie bei Patienten mit Substanzabhängigkeitssyndrom. Schmerz. 2018;32(2):131-8. [DOI: 10.1007/s00482-018-0269-7]

[71] Solomons YF, Moipolai PD. Substance abuse: case management and dental treatment. SADJ. 2014;69(7):298-315. [Link]

[72] Scully C. Oral and maxillofacial medicine: the basis of diagnosis and treatment. 3rd ed. Churchill Livingstone; 2012. [Link]

[73] Braga MM, Mendes FM, Ekstrand KR. Detection activity assessment and diagnosis of dental caries lesions. Dent Clin North Am. 2010;54(3):479-93. [DOI: 10.1016/j.cden.2010.03.006]

[74] Rajasekaran JJ, Krishnamurthy HK, Bosco J, Jayaraman V, Krishna K, Wang T, et al. Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. Microorganisms. 2024;12(9):1797. [DOI: 10.3390/microorganisms12091797]

[75] Hanson GR, McMillan S, Mower K, Bruett CT, Duarte L, Koduri S, et al. Comprehensive oral care improves treatment outcomes in male and female patients with high-severity and chronic substance use disorders. J Am Dent Assoc. 2019;150(7):591-601. [DOI: 10.1016/j.adaj.2019.02.016]

[76] Al-Hashimi H. Impact of Chronic Cannabis Use on Oral and Periodontal Health: A Comprehensive Literature Review. Int J Compr Health Med Dent. 2026;2(1):67-81. [DOI: 10.64950/ijchmd.32]

[77] Yu CW, Sun R, Hu M. Disposition Factors Impacting Buprenorphine Salivary Gland Accumulation and Oral Fluid Exposure. Curr Addict Rep. 2025;12(1):53. [DOI: 10.1007/s40429-025-00662-7]

[78] Sadeghi F, Hashemzade Z, Farzad A, Azadchehr M J. Psychosocial Ramifications of Perceived Dental Aesthetics: A Cross-Sectional Analysis of Oral Health-Related Quality of Life Outcomes. Int J Med Toxicol Forensic Med. 2026;16:1-6. [DOI: 10.22037/ijmtfm.v16.52912]

[79] Tamtaji OR, Milajerdi A, Reiner Ž, Asemi Z, Dadgostar E, Heidari-Soureshjani R, et al. A systematic review and meta-analysis: The effects of probiotic supplementation on metabolic profile in patients with neurological disorders. Complement Ther Med. 2020;53:102507. [DOI: 10.1016/j.ctim.2020.102507]

[80] Samiei F, Jamshidzadeh A, Noorafshan A, Ghaderi A. Human Placental Extract Ameliorates Structural Lung Changes Iinduced by Amiodarone in Rats. Iran J Pharm Res. 2016;15(Suppl):75-82. [DOI: 10.22037/ijpr.2016.1808]